IL6 and colorectal cancer: Furthermore, the study suggests that the IL-6/STAT3 pathway enhances miR-92a expression by directly targeting its promoter, resulting in the activation of Wnt/β-catenin signaling and the subsequent promotion of stem-like traits in colorectal cancer cells.